Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...

In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

If tirzepatide remains off the FDA's drug shortage list, compounding pharmacies ... that is "essentially a copy of one or more approved drug products." However, a compounded drug may qualify ...

Heron Therapeutics, Inc., a commercial-stage biotechnology company, announced that the US Food and Drug Administration (FDA) has approved the company's Prior Approval Supplement Application for ...

If the FDA agrees with DSM-Firmenich's request, the next step will be for the FDA to propose adding bemotrizinol to the list of over-the ... "Consumers are purchasing products with bemotrizinol ...

today announced that the U.S. Food and Drug Administration (the "FDA") has approved the Company's Prior Approval Supplement Application for ZYNRELEF® (bupivacaine and meloxicam) extended-release ...